Integrons are genetic elements consisting of a functional platform for recombination and expression 20 of gene cassettes (GCs). GCs usually carry promoter-less open reading frames (ORFs), encoding 21 proteins with various functions including antibiotic resistance. The transcription of GCs relies mainly 22 on a cassette promoter (PC), located upstream of an array of GCs. Some integron GCs, called ORF-less 23 GCs, contain no identifiable ORF with a small number shown to be involved in antisense mRNA 24 mediated gene regulation. 25
Detection of promoter-containing GCs from oral metagenome. 117
The pCC1BAC-lacZα-gusA plasmid, developed for the above enzymatic assay, had the potential to be 118 used in an agar plate-based detection strategy to detect amplified integron GCs with promoter activity 119 on either strand of DNA. This construct is called the Bi-Directional Promoter Detection plasmid 120 (pBiDiPD). To verify the utility of pBiDiPD, and also to detect novel GCs containing promoter sequences 121 in the human oral metagenome, integron GCs were amplified with SUPA4-NsiI/SUPA3-NheI and 122 MARS5-NsiI/MARS2-NheI primers [28] , and cloned into pBiDiPD. By spreading transformants on LB 123 plates containing X-gal/IPTG and 4-methylumbelliferyl β-D-glucuronide (MUG), clones containing 124 inserts with promoter activity in either direction could be identified. The clones with GCs containing a 125 promoter on the sense strand showed blue fluorescence when visualised under UV light, reflecting the 7 recovered promoter-containing GCs, 9 out of 23 were novel including sample SSU-Pro-20, SSU-Pro-27, 134 SSU-Pro-32, SSU-Pro-46, SSU-Pro-65, MMU-Pro-5, MMU-Pro-24, and MMU-Pro-53. Artefactual PCRs 135 were discounted by detecting the consensus R' (1R) core sites [GTTRR(Y)R(Y)Y(R)] and the 136 complementary R'' (1L) core sites [R(Y)Y(R)Y(R)YAAC] of attC located downstream from the attC 137 forward primers and upstream from the attC reverse primers, respectively ( Supplementary Table 1 ) 138 [35] . 139
The GCs can be categorised into two groups, one predicted to encode toxin-antitoxin systems in 12 140 out of 23 GCs, including plasmid stabilization protein (toxin)-prevent-host-death protein (antitoxin), 141
BrnT (toxin)-BrnA (antitoxin), VapC (toxin)-AbrB/MazE/SpoVT family protein (antitoxin), RelE/ParE 142 family (toxin)-XRE transcriptional regulator (antitoxin). The second group contained ORF-less GCs, 143 which could be found in 7 samples, all reported in the previous study, except sample MMU- Most of the samples (14 out of 23 GCs) showed the promoter activity only on the sense strand. 145
Samples with promoter activity only on the antisense strand were MMU-Pro-6, MMU-Pro-63, and 146 MMU-Pro-65, while 6 out of 23 GCs exhibited promoter activity on both strands. 147
Discussion 148
Integrons are important disseminators of antimicrobial resistance genes and therefore, it is important 149 to understand the diversity of GCs and how their expression is controlled. Even though most of the 150 GCs contained a single ORF, ORF-less GCs have also been found [24, 27, 28, 36, 37] . 151
In this study, we determined promoter activity from GCs isolated by PCR from metagenomic DNA by 152 measuring promoter activity from multiple GC containing constructs. As the ORF-less GCs were 153 recovered from the oral metagenome, there is little information regarding the original host. Therefore, 154 we chose to test the promoter activities by using an E. coli surrogate. Nucleotide sequence analysis 155 suggested that these GCs were likely to be derived from Treponema spp., therefore, the ability of E. 156 coli to utilise T. denticola promoter sequences was determined by including the experimentally verified providing confidence that E. coli could be used. However, as no promoter activity was detected from 159 PFla, it suggested that our enzymatic assay cannot detect promoters associated with σ 28 from 160
Treponema spp., which could be due to an inability for the E. coli host to recognise the Treponema σ 28 161 promoter sequence. 162
Promoter activities of the ORF-less GCs were confirmed and quantified by using a β-glucuronidase 163 enzymatic assay. This is the first time that the promoter activity of ORF-less GCs has been 164 demonstrated in vitro, as shown by the activity on the sense strand of the MMB37 and both strands 165 of the TMB4. A study on the Vibrio integron, containing a 116-cassette array, showed that most of the 166 GCs are transcribed [38] . Therefore, ORF-less GCs could be responsible for transcription of the other 167
GCs not transcribed by PC. 168
For the TMB4 GC (ORF-less GC in the first position), it was initially hypothesised that the promoter 169 could help increase the expression of the downstream GCs. This was shown when PC promoter was 170 coupled with a second promoter (P2) (found in 10% of class 1 integron and located 119 bp downstream 171 from PC), could result in a significantly higher expression of GCs [39, 40] . The constructs of TMB4 PC 172 and TMB4 PC+GC were therefore included in the assay to determine whether having a promoter GC at 173 the first position could help promote the expression of downstream GCs. The results show that 174 coupling promoter GC in the first position slightly increased the expression of reporter genes ( Fig. 3) . 175
However, this was not significant (p-value >0.99 by using ordinary one-way ANOVA followed by 176
Bonferroni's post-hoc). 177
The lack of additive promoter activity can be explained by more competition for enzymes involved in 178 transcription such as RNA polymerases (RNAP) or sigma factors to be available for transcription from 179 each promoter, resulting in lower transcriptional level [41] . Another, not mutually exclusive possibility experimentally shown promoter activity of TMB4 PC and TMB4 GC constructs on both strands, 182 indicating convergent TI is a possibility. 183
In usual integrons, PC is in intI, which is convergent to the integron integrase promoter PIntI downstream 184 ( Fig 1) , resulting in TI. The TI between PC and PIntI has been shown to control the expression of integrase 185 and the subsequent recombination of GCs. The weaker strength of PC could result in higher expression 186 of integrase, which increases recombination of GCs [42, 43] . This relationship of PC and intI might also 187 apply to the reverse integrons found in T. denticola, even though their position and direction of PintI, 188 PC and intI gene are in a different orientation compared to the usual integrons (Fig 1) . 189
Due to the lack of additive promoter activity when Pc and an ORF-less GC promoter were tested in 190 tandem we hypothesised that there is an alternative selective advantage for having an ORF-less, 191
promoter-containing GC in the first position on an integron GC array. 192
The expression level of cassette genes located further down in the array normally decreases due to 193 the formation of a stem-loop structure on mRNA at attC sites, which impede the progression of the 194 ribosome [44] . It was previously shown that the level of streptomycin resistance was reduced four 195 times, when the aadA2-containing GC was located in the second position [45] . However, our data 196 shows that the insertion of an ORF-less, promoter-containing GC in the first position did not decrease 197 the gusA expression significantly (considered as a proxy for the expression of gene(s) in the second 198 GC), i.e. comparing the data for TMB4 PC and TMB4 PC+GC. Therefore, we hypothesised that promoter-199 containing GCs could act as a genetic clutch, where the expression of the original first GC is partially 200 disengaged from the PC promoter and replaced by the one on the ORF-less promoter containing GC 201 ( Fig 5A) . This can prevent a significant change in expression of the first GC while a new, first GC is 202 sampled from the pool of GCs in order to adapt to an additional stress concurrent with the selective 203 pressure requiring expression of the first GC. This system would work as a genetic clutch with the 204 insertion of any GC containing a promoter in the same direction as PC, so it could be the insertion of 205 either ORF-less GCs such as TMB4 GC, or other promoter-containing GCs such as the multiple TA-206 containing GCs we have identified; providing another selective advantage to retaining them and 207 explaining their varied position within the GC array. 208 A genetic clutch within an integron can be of benefit to bacteria when they are exposed to multiple 209 environmental stresses such as two different antibiotics simultaneously. The first resistance gene 210 (green ORF in Fig 5Biii) can be expressed by the PC promoter, while the second resistance gene (blue 211 GC), located in the third position, is expressed by PC and the promoter GC. Therefore, allowing bacteria 212 to survive in both the presence of both drugs. 213
As the other ORF-less GC MMU23 showed no promoter activity it may have other functions or carry a 214 promoter that can be recognised in its native host but not in E. coli, or require other sigma factors. For 215 the ORF-containing GC MMB3 sample, the promoter activity was found on the sense strand. This GC 216 was predicted to carry toxin-antitoxin (TA) ORFs, including the PIN toxin and ribbon-helix-helix 217 antitoxin domains, which were shown to contain their own promoter. Sample SSU17 and MMU23, 218 which showed no promoter activity, can be considered as a control; illustrating that not all of GCs 219 amplified from the oral metagenome exhibited promoter activity within our assay. 220
The pCC1BAC-lacZα-gusA plasmid, developed for the enzymatic assay, also had potential to be used 221 for the detection of promoter activity in either direction from GCs. The clones with promoters on the 222 sense strand can be detected under UV light and showed blue fluorescence because β-glucuronidase 223 can cleave the substrate, MUG, on the plate, which produces a fluorescence compound called 224 methylumbelliferone. For the clones carrying promoters on the antisense strand, they can be detected 225 by blue-white screening as β-galactosidase can cleave X-gal, producing an intensively blue product 226 called 5,5'-dibromo-4,4'-dichloro-indigo, which can be viewed by eye under normal light. 227
To verify the application of pCC1BAC-lacZα-gusA plasmids as promoter detection system, integron GCs 228 were amplified from the human saliva metagenome by using SUPA3-SUPA4 and MARS2-MARS5 between both reporter genes, two groups of GCs were identified with promoter activities: ORF-less 231
GCs and TA-containing GCs. By detecting 7 clones containing ORF-less GCs with promoter activity it 232 further supported that one of the functions of ORF-less GCs in integrons is to provide promoter 233 activities. 234 TA-containing GCs are abundant in chromosomal integrons (CIs), which were suggested to have a role 235 in preventing random deletion of GCs and stabilising the large arrays CIs [22, 46, 47] . TA systems 236 normally encode a stable toxin and a labile antitoxin [48], therefore TA cassettes have to carry their 237 own promoters to ensure their expression. These were found in CIs of Treponema spp., such as the 238
HicA-HicB TA-containing GC in the fourth position within the GC array (Accession number NC_002967) 239 in the CI from T. denticola [30] . As most of the GCs amplified with our primers were homologous with 240
Treponema spp., these TA-containing GCs should be present in our oral metagenome and were 241 detected by our pBiDiPD based on their promoter activities. 242
Two of the GCs, SSU-Pro-9 and MMU-Pro-18, were similar to the MMB3 and MMB37 GCs, respectively, 243 which were shown by the β-glucuronidase enzyme assay to have promoter activity on the sense 244 strand. The phenotypes of SSU-Pro-9 and MMU-Pro-18 colonies also showed only a blue fluorescence 245 phenotype, reflecting the promoter activity on the sense strand, which corresponded with the 246 enzymatic assay results of MMB3 and MMB37. 247
To summarise, the promoter activities of the ORF-less integron GCs were experimentally 248 demonstrated by using a robust β-glucuronidase enzyme assay, confirming that one of the functions 249 of ORF-less GCs is to provide promoters for the expression of ORF containing GCs, in addition to 250 expression from PC. The dual reporter plasmid; pBiDiPD, was developed for the direct visualisation of 251 clones containing gene cassettes with promoter activity on agar plates. This can be applied as a 252 detection system for promoter activity for any other DNA fragments. 253 254 in silico analysis of the human oral cavity gene cassettes and the construction of pCC1BAC-lacZα-GC-256 gusA constructs. 257
All of the ORF-less GCs and some of the GCs containing ORFs, identified in the previous study [28] , 258 were predicted for putative promoter sequences by using the web-based software BPROM in the 259 Softberry package [49] . 260
Construction of pUC19-GC-gusA and pCC1BAC-lacZα-GC-gusA constructs. 261
To determine the promoter activity of the selected GCs, the constructs were initially cloned into the 262 EcoRI and KpnI restriction sites on pUC19-Ptet(M)-gusA plasmid [50]. The selected GCs were amplified 263 from the pGEM-T easy vector containing the GC amplicon from a previous study [28] , as shown in 264 Supplementary Fig 1, by using primer listed in Supplementary Table 2 . 265
Due to a significant difference in the plasmid copy number in some constructs of the pUC19-GC-gusA, 266 new constructs were prepared based on a low copy number CopyControl™ pCC1BAC™ vector 267 (Epicenter, UK) as it will be maintained in E. coli cell as one plasmid per cell and enable us to control 268 the plasmid copy number to be similar between each construct. The construct was designed to contain 269 two reporter genes, β-galactosidase lacZα and β-glucuronidase gusA genes ( The selected GCs were amplified from each pUC19-GC-gusA constructs by using primer listed in 290 Supplementary Table 1 . The amplicons were double digested with NsiI and NheI and directionally 291 cloned into a pre-digested pCC1BAC-lacZα-gusA plasmid, then transformed into E. coli α-Select Silver 292
Efficiency competent cells. 293

Determination of β-glucuronidase enzymatic activity. 294
The β-glucuronidase enzymatic assay was performed to measure the promoter activity based on the 295 expression of gusA, following the protocol described previously with some modifications [52] . The 296 overnight cultures of E. coli containing the reporter constructs were prepared in LB broth 297 supplemented with 12.5 µg/mL chloramphenicol. The OD600 of each overnight culture was measured. 298
An aliquot of 1 mL of the overnight culture was centrifuged at 3000 x g for 10 min and discarded the 299 supernatant. The cell pellets were incubated at -70°C for 1 hr and resuspended in 800 µl of pH 7 Z 300 buffer (50 mM 2-mercaptoethanol, 40 mM NaH2PO4·H2O, 60 mM Na2HPO4·7H2O, 10 mM KCl, and 1mM 301 MgSO4·7H2O) and 8 µl of toluene. The mixture was transferred to a 2 ml cryotube containing glass 302 beads (150-212 μm in diameter) (Sigma, UK) and vortexed twice for 5 min each with an incubation on ice for 1 min in between. The glass beads were then removed by centrifugation at 3000 x g for 3 min. 304
One-hundred microliters of cell lysate were mixed with 700 µl of Z-buffer, then incubated at 37°C for 305 5min. One-hundred sixty microliters of 6 mM ρ-nitrophenyl-β-D-glucuronide (PNPG) was then added 306 to the reaction and incubated at 37°C for 5 min. The reactions were stopped by adding 400 µl of 1 M 307 Na2CO3 and centrifuged at 3000 x g for 10 min to remove cell debris and glass beads. Biotechnology Information (NCBI), respectively. The criteria for the sequence analysis of integron GC 341 were the same as described in the previous study [28] . Two additional criteria for the verification of 342
GCs detected with pCC1BAC-lacZα-gusA were included. Any clones containing incomplete GCs, caused 343 by digestion at internal NsiI and NheI restriction sites on the GCs, were excluded from the dataset. 344
Also chimeric inserts, which were the ligation products between digested amplicons, were also 345 excluded. 346
The promoter-containing GCs were named as described in the previous study [28] . The first and second 347 letters represented the forward primer and reverse primer used in the amplification. The third letter 348 represents the source of the human oral metagenomic DNA which is U for the United Kingdom. This 349 was followed by term "Pro", indicating the presence of promoter activity, and the number of the clone. 
